Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2012
06/27/2012CN102145070B Traditional Chinese medicine for treating rheumatic heart disease
06/27/2012CN102145059B Chinese patent medicament for treating intractable hypertension
06/27/2012CN102133197B Valsartan lipid microsphere solid preparation
06/27/2012CN102133192B Candesartan cilexetil lipid nanoparticle solid preparation
06/27/2012CN102133189B Telmisartan liposome solid preparation
06/27/2012CN102133175B Amygdalin gel and preparation method and medicinal application thereof
06/27/2012CN102119943B Moringa oil emulsion
06/27/2012CN102106927B Fat-clearing pressure-reducing tea
06/27/2012CN102091298B Use of medicinal composition prepared by using zedoary turmeric oil and borneol as raw materials
06/27/2012CN102078533B Drug for treating hypertension
06/27/2012CN102068450B Application of aucubin to preparation of anti-thrombosis medicament
06/27/2012CN102018949B Traditional Chinese medicine composition for treating vertigo
06/27/2012CN101961405B Method for testing content of pinoresinol diglucoside in compound eucommia bark tablet
06/27/2012CN101961309B Process for preparing pantoprazole sodium for injection
06/27/2012CN101947254B Method for extraction of total salvianolic acid from salvia miltrorrhiza ethanol-precipitation precipitates
06/27/2012CN101912572B Multi-effect external plaster
06/27/2012CN101856466B Medicine preventing and treating hypertension and stroke and being prepared by dendrobium officinale flower and method
06/27/2012CN101856403B Medicinal composition, preparation method thereof and pharmaceutical application
06/27/2012CN101850031B Pueraria isoflavone capsule
06/27/2012CN101816667B Application of forsythiaside A in preparation of drugs for preventing and treating cardiovascular and cerebrovascular diseases
06/27/2012CN101791332B Compound gingko health product solid preparation
06/27/2012CN101773493B New application of medicine compound brazilein
06/27/2012CN101744938B Pharmaceutical composition and preparation method thereof
06/27/2012CN101732330B Phtneolamine mesilate and fructose composition, preparation method thereof and use thereof
06/27/2012CN101716236B Chinese medicinal composition for adjunctively treating left ventricular insufficiency after acute myocardial infarction and preparation method thereof
06/27/2012CN101698050B Application of traditional Chinese medicine composite in preparing medicine treating paroxysmal atrial fibrillation
06/27/2012CN101613679B Rhabdovirus with recombination superoxide dismutase gene and preparation and application thereof
06/27/2012CN101612171B Ginkgo biloba extract sustained-release pellet and preparation method thereof
06/27/2012CN101601813B Medicament for treating hypertensive renal damage and preparation method thereof
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101564180B Walnut total nutriment and soft capsule and health products containing same
06/27/2012CN101559114B Application of traditional Chinese medicine composition in preparing antihypoxic
06/27/2012CN101553568B Neukinase, a downstream protein of neuregulin
06/27/2012CN101474195B Medicament composition for treating cardiac and cerebral vascular disease
06/27/2012CN101468058B Tiangua tinea and bacterium eliminating agent for treating dermatopathy and preparation method thereof
06/27/2012CN101439077B Medicament containing dalbergia heartwood for treating blood vessel endothelium dysfunction and preparation method thereof
06/27/2012CN101254248B Applications of Chinese medicinal composition for preparing medicament for curing chronic fatigue syndrome medicament
06/27/2012CN101133787B Wilding synthesized black rice black soya bean compressed food granules beverage and method of processing the same
06/27/2012CN101032562B Health care product having functions of conditioning blood pressure and protecting haemal system of heart and brain
06/26/2012US8207219 Ion channel modulating activity I
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207168 Pyridazinone derivatives
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012US8207137 administering a therapeutically effective amount of an active agent selected from the group consisting of a protein substance including all or part of a disintegrin domain of an adamalysin or a derivative thereof
06/26/2012US8206947 Human transmembrane proteins
06/26/2012US8206739 Fish protein hydrolyzate
06/26/2012US8206719 KDR peptides and vaccines comprising the same
06/26/2012US8206716 Methods of treating with anti-C5/C5a specific antibodies
06/26/2012US8206714 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
06/26/2012US8206708 Vascular endothelial growth factor 2
06/26/2012CA2575232C 5-substituted-2-phenylamino-benzamide as mek inhibitor
06/26/2012CA2511970C Urea derivatives useful in the treatment of heart failure
06/26/2012CA2508129C Novel x-conotoxin peptides (-i)
06/26/2012CA2504941C 3-substituted-6-aryl pyridines
06/26/2012CA2432474C Fibrin binding polypeptides useful inter alia in medical imaging processes
06/21/2012WO2012081905A2 Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirin
06/21/2012WO2012081736A1 Continuous arycyclic compound
06/21/2012WO2012081713A1 Therapeutic agent for blood-brain barrier disruption syndrome
06/21/2012WO2012081711A1 Cell migration modulator
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081570A1 Lactam compound or a salt thereof, and ppar activator
06/21/2012WO2012081563A1 Benzothiazole and azabenzothiazole derivative having endothelial lipase inhibitory activity
06/21/2012WO2012081040A1 Biological activity of placental protein 13
06/21/2012WO2012080982A2 Functional food preparation and use thereof
06/21/2012WO2012080976A1 Lar protein-specific ligand
06/21/2012WO2012080831A1 Composition for the treatment of metabolic disorders
06/21/2012WO2012080762A1 Novel inhibitors of matrix metalloproteinases
06/21/2012WO2012080333A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012WO2012080144A1 Oxime compounds as hdl-cholesterol raising agents
06/21/2012WO2012079721A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
06/21/2012WO2012079419A1 Pharmaceutical composition for treating macular degeneration
06/21/2012WO2012079311A1 A sea cucumber compound product, preparation method and preparation forms thereof
06/21/2012WO2012079310A1 Sea cucumber compound preparation and preparation method thereof
06/21/2012WO2012079203A1 Puerarin hydrates, preparation methods and uses thereof
06/21/2012WO2012079146A1 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation
06/21/2012WO2012027514A3 Compositions and methods for cardiac therapy
06/21/2012US20120157751 Intracoronary device and method of use thereof
06/21/2012US20120157543 Preparation of (r,r)-fenoterol and (r,r)-or (r,s)-fenoterol analogues and their use in treating congestive heart failure
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157526 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
06/21/2012US20120157516 Novel thiophene compounds for use in therapy
06/21/2012US20120157513 Small Peptide Expression System in Mammalian Cells
06/21/2012US20120157507 USP47 Inhibtors and Methods to Induce Apoptosis
06/21/2012US20120157504 New Process
06/21/2012US20120157482 Compounds and methods
06/21/2012US20120157476 Oxime compounds
06/21/2012US20120157473 Therapeutic methods and compounds
06/21/2012US20120157454 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
06/21/2012US20120157453 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157433 Heteroaryl Compounds as Kinase Inhibitors
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157424 Treatment of menopause-associated symptoms
06/21/2012US20120157420 Treatment and prevention of secondary injury after trauma or damage to the central nervous system
06/21/2012US20120157415 New Crystalline Form of Pemirolast
06/21/2012US20120157414 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157407 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
1 ... 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 ... 1595